3,124
Views
53
CrossRef citations to date
0
Altmetric
Research Article

The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered-Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study

Pages 216-225 | Received 21 May 2014, Accepted 02 Jul 2014, Published online: 13 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Waiting Tai & Philip Chi Lip Kwok. (2022) Recent advances in drug delivery to the central nervous system by inhalation. Expert Opinion on Drug Delivery 19:5, pages 539-558.
Read now
Lidya Kebede, Seyedehsara Masoomi Dezfooli & Ali Seyfoddin. (2022) Medicinal cannabis pharmacokinetics and potential methods of delivery. Pharmaceutical Development and Technology 27:2, pages 202-214.
Read now
Yara Mouhamed, Andrey Vishnyakov, Bessi Qorri, Manpreet Sambi, SM Signy Frank, Catherine Nowierski, Anmol Lamba, Umrao Bhatti & Myron R Szewczuk. (2018) Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. Drug, Healthcare and Patient Safety 10, pages 45-66.
Read now

Articles from other publishers (49)

Rebecca M. Craft, Hannah Y. Gogulski, Timothy G. Freels, Nicholas C. Glodosky & Ryan J. McLaughlin. (2023) Vaporized cannabis extract–induced antinociception in male vs female rats with persistent inflammatory pain. Pain 164:9, pages 2036-2047.
Crossref
Ivan A. RossIvan A. Ross. 2023. Plant-Based Therapeutics, Volume 1. Plant-Based Therapeutics, Volume 1 249 301 .
Philip Schmiedhofer, Florian Daniel Vogel, Filip Koniuszewski & Margot Ernst. (2022) Cys-loop receptors on cannabinoids: All high?. Frontiers in Physiology 13.
Crossref
Joshua Aviram, Daniella Atzmony, Anna Frenklakh, Asaf Kroll, Ilana Zaks & Arno Hazekamp. (2022) THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial. Journal of Cannabis Research 4:1.
Crossref
Paolo Poli, Luana Peruzzi, Pierdomenico Maurizi, Antonella Mencucci, Antonella Scocca, Simona Carnevale, Ottavia Spiga & Annalisa Santucci. (2022) The Pharmacogenetics of Cannabis in the Treatment of Chronic Pain. Genes 13:10, pages 1832.
Crossref
Anaëlle Monfort, Ema Ferreira, Grégoire Leclair & Gregory Anton Lodygensky. (2022) Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding. Frontiers in Pharmacology 13.
Crossref
Yuma T. Ortiz, Lance R. McMahon & Jenny L. Wilkerson. (2022) Medicinal Cannabis and Central Nervous System Disorders. Frontiers in Pharmacology 13.
Crossref
Walter Zieglgänsberger, Rudolf Brenneisen, Achim Berthele, Carsten T. Wotjak, Borwin Bandelow, Thomas R. Tölle & Beat Lutz. (2022) Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option?. Medical Cannabis and Cannabinoids 5:1, pages 61-75.
Crossref
Helen Senderovich, Hayley Wagman, Dennis Zhang, Danusha Vinoraj & Sarah Waicus. (2022) The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review. Gerontology 68:6, pages 612-624.
Crossref
Joshua Aviram, Daniella Atzmony & Elon Eisenberg. (2022) Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler. PAIN Reports 7:3, pages e1011.
Crossref
Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark & Mark S Wallace. (2021) The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. JNCI Monographs 2021:58, pages 86-98.
Crossref
Alessandra Bennici, Carmen Mannucci, Fabrizio Calapai, Luigi Cardia, Ilaria Ammendolia, Sebastiano Gangemi, Gioacchino Calapai & Daniel Griscti Soler. (2021) Safety of Medical Cannabis in Neuropathic Chronic Pain Management. Molecules 26:20, pages 6257.
Crossref
David P. Finn, Simon Haroutounian, Andrea G. Hohmann, Elliot Krane, Nadia Soliman & Andrew S.C. Rice. (2021) Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. Pain 162:1, pages S5-S25.
Crossref
Jenny L. Wilkerson, Joshua A. Bilbrey, Jasmine S. Felix, Alexandros Makriyannis & Lance R. McMahon. (2021) Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?. Pharmacology Biochemistry and Behavior 206, pages 173192.
Crossref
Khadijeh Mozaffari, Stephanie Willette, Ben F. Lucker, Sarah E. Kovar, Francisco Omar Holguin & Ivette Guzman. (2021) The Effects of Food on Cannabidiol Bioaccessibility. Molecules 26:12, pages 3573.
Crossref
Rishabh Verma, Farazul Hoda, Mawrah Arshad, Asif Iqubal, Ali Nasir Siddiqui, Mohammad Ahmed Khan, Syed Ehtaishamul Haque, Mohd Akhtar & Abul Kalam Najmi. (2021) Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence. Medical Cannabis and Cannabinoids 4:1, pages 43-60.
Crossref
Shah Khalid, Faisal A. Almalki, Taibi Ben Hadda, Ammar Bader, Tareq Abu-Izneid, Malika Berredjem, Eman R. Elsharkawy & Ali M. Alqahtani. (2021) Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?. Current Pharmaceutical Design 27:13, pages 1564-1578.
Crossref
Maria Fernanda Arboleda & Erin Prosk. 2021. Cannabinoids and Pain. Cannabinoids and Pain 153 165 .
Marta Vázquez, Carlos García-Carnelli, Cecilia Maldonado & Pietro Fagiolino. 2021. Cannabinoids and Sleep. Cannabinoids and Sleep 27 42 .
Offir Ben-Ishay, Ortal Bar-On & Yoram Kluger. (2020) Smokeless consumption of medical cannabis pharmacokinetics, safety and feasibility of the CannaHALER© a phase 1a study. Journal of Cannabis Research 2:1.
Crossref
Lucas FirstWilliam DouglasBehnum HabibiJaspal Ricky SinghMichael T. Sein. (2020) Cannabis Use and Low-Back Pain: A Systematic Review. Cannabis and Cannabinoid Research 5:4, pages 283-289.
Crossref
John A Sturgeon, James Khan, Jennifer M Hah, Heather Hilmoe, Juliette Hong, Mark A Ware & Sean C Mackey. (2020) Clinical Profiles of Concurrent Cannabis Use in Chronic Pain: A CHOIR Study. Pain Medicine 21:11, pages 3172-3179.
Crossref
Mark S. Wallace, Thomas D. Marcotte, J.H. Atkinson, Hayley Treloar Padovano & Marcel Bonn-Miller. (2020) A Secondary Analysis from a Randomized Trial on the Effect of Plasma Tetrahydrocannabinol Levels on Pain Reduction in Painful Diabetic Peripheral Neuropathy. The Journal of Pain 21:11-12, pages 1175-1186.
Crossref
Shlomo Almog, Judith Aharon‐Peretz, Simon Vulfsons, Miri Ogintz, Hadas Abalia, Tal Lupo, Yael Hayon & Elon Eisenberg. (2020) The pharmacokinetics, efficacy, and safety of a novel selective‐dose cannabis inhaler in patients with chronic pain: A randomized, double‐blinded, placebo‐controlled trial. European Journal of Pain 24:8, pages 1505-1516.
Crossref
R. G. Akzhigitov, K. I. Pochigayeva, F. K. Rider, A. M. Teplyshova, S. I. Dedayev, I. A. Shpak, E. V. Pashnin & A. B. Gekht. (2020) The use of cannabinoids in epilepsy as an example: medical, social, and legal aspects. Neurology, Neuropsychiatry, Psychosomatics 12:4, pages 125-130.
Crossref
Laura Carrara, Christian Giroud & Nicolas Concha-Lozano. (2020) Development of a Vaping Machine for the Sampling of THC and CBD Aerosols Generated by Two Portable Dry Herb Cannabis Vaporisers. Medical Cannabis and Cannabinoids 3:1, pages 84-94.
Crossref
Dvora Izgelov, Michael Freidman & Amnon Hoffman. (2020) Investigation of cannabidiol gastro retentive tablets based on regional absorption of cannabinoids in rats. European Journal of Pharmaceutics and Biopharmaceutics 152, pages 229-235.
Crossref
Galit Weinstein & Sharon R. Sznitman. (2020) The implications of late-life cannabis use on brain health: A mapping review and implications for future research. Ageing Research Reviews 59, pages 101041.
Crossref
Dvora Izgelov, Eliyahu Shmoeli, Abraham J. Domb & Amnon Hoffman. (2020) The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats. International Journal of Pharmaceutics 580, pages 119201.
Crossref
Simon Vulfsons, Miriam Ognitz, Gil Bar-Sela, Ayelet Raz-Pasteur & Elon Eisenberg. (2019) Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study. Palliative and Supportive Care 18:1, pages 12-17.
Crossref
Mari Kannan Maharajan, Yu Jing Yong, Hong Yang Yip, Sze Shee Woon, Kar Mon Yeap, Khai Yeng Yap, Shuen Chi Yip & Kai Xian Yap. (2019) Medical cannabis for chronic pain: can it make a difference in pain management?. Journal of Anesthesia 34:1, pages 95-103.
Crossref
J. M. Chatkin, L. Zani-Silva, I. Ferreira & N. Zamel. (2017) Cannabis-Associated Asthma and Allergies. Clinical Reviews in Allergy & Immunology 56:2, pages 196-206.
Crossref
Eric P. Baron, Philippe Lucas, Joshua Eades & Olivia Hogue. (2018) Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. The Journal of Headache and Pain 19:1.
Crossref
Joseph V. Pergolizzi Jr.Jo A. Lequang, Robert Taylor Jr.Robert B. Raffa & Daniel Colucci. (2018) The role of cannabinoids in pain control: the good, the bad, and the ugly. Minerva Anestesiologica 84:8.
Crossref
Eric P. Baron. (2018) Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache: The Journal of Head and Face Pain 58:7, pages 1139-1186.
Crossref
Terrance Bellnier, Geoffrey W. Brown & Tulio R. Ortega. (2018) Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. Mental Health Clinician 8:3, pages 110-115.
Crossref
Irina Cherniakov, Dvora Izgelov, Dinorah Barasch, Elyad Davidson, Abraham J. Domb & Amnon Hoffman. (2017) Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration. Journal of Controlled Release 266, pages 1-7.
Crossref
Irina Cherniakov, Dvora Izgelov, Abraham J. Domb & Amnon Hoffman. (2017) The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model. European Journal of Pharmaceutical Sciences 109, pages 21-30.
Crossref
José Miguel Chatkin, Gustavo Zabert, Ignacio Zabert, Gustavo Chatkin, Carlos Andrés Jiménez-Ruiz, Jose Ignacio de Granda-Orive, Daniel Buljubasich, Segismundo Solano Reina, Ana Figueiredo, Sofia Ravara, Juan Antonio Riesco Miranda & Christina Gratziou. (2017) Patología pulmonar asociada al consumo de marihuana. Archivos de Bronconeumología 53:9, pages 510-515.
Crossref
José Miguel Chatkin, Gustavo Zabert, Ignacio Zabert, Gustavo Chatkin, Carlos Andrés Jiménez-Ruiz, Jose Ignacio de Granda-Orive, Daniel Buljubasich, Segismundo Solano Reina, Ana Figueiredo, Sofia Ravara, Juan Antonio Riesco Miranda & Christina Gratziou. (2017) Lung Disease Associated With Marijuana Use. Archivos de Bronconeumología (English Edition) 53:9, pages 510-515.
Crossref
Jos?e Guindon. (2017) A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence. Neuropharmacology 114, pages 168-171.
Crossref
Matthew B Yuill, David E Hale, Josée Guindon & Daniel J Morgan. (2017) Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain. Molecular Pain 13, pages 174480691772822.
Crossref
Michelle SextonCarrie CuttlerJohn S. FinnellLaurie K. Mischley. (2016) A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy. Cannabis and Cannabinoid Research 1:1, pages 131-138.
Crossref
Staci A. Gruber, Kelly A. Sagar, Mary K. Dahlgren, Megan T. Racine, Rosemary T. Smith & Scott E. Lukas. (2016) Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function. Frontiers in Pharmacology 7.
Crossref
Ethan B. Russo. (2016) Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues. Frontiers in Pharmacology 7.
Crossref
Seddon R. Savage, Alfonso Romero-Sandoval, Michael Schatman, Mark Wallace, Gilbert Fanciullo, Bill McCarberg & Mark Ware. (2016) Cannabis in Pain Treatment: Clinical and Research Considerations. The Journal of Pain 17:6, pages 654-668.
Crossref
Rafael Maldonado, Josep Eladi Baños & David Cabañero. (2016) The endocannabinoid system and neuropathic pain. Pain 157:Supplement 1, pages S23-S32.
Crossref
Jane Sachs, Erin McGlade & Deborah Yurgelun-Todd. (2015) Safety and Toxicology of Cannabinoids. Neurotherapeutics 12:4, pages 735-746.
Crossref
Caroline A. Arout, Ellen Edens, Ismene L. Petrakis & Mehmet Sofuoglu. (2015) Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations. CNS Drugs 29:6, pages 465-486.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.